Wateya "Paqij" çi ye?
Heywan mutasyon hilnagire. Wê nexweşî pêş nekeve û wê derbas neke.
Seh Mîopatiya Navokî ya Navendî ya Li Border Collie (CNM-BC)
Centronuclear Myopathy (CNM) is a genetic disorder affecting Border Collies, characterized by muscle weakness and exercise intolerance. A DNA test for CNM is essential for responsible breeding, helping to identify carriers and reduce the risk of this debilitating condition. This simple yet effective test enables dog owners and breeders to make informed decisions, ensuring healthier puppies. By understanding the genetic predisposition to CNM, owners can provide better care and management for affected dogs. Regular screening through DNA testing not only promotes the health of individual dogs but also contributes to the overall well-being of the Border Collie breed. Invest in a CNM DNA test today to safeguard your canine companion’s future.
Kurtekirin : CNM-BC
Mutasyona analîzkirî: DNM2 c.1393C>T
Mîras: Autosomal Recessive
Acronym
CNM-BC
Frequency çavdêrî kirin
Zehmetiya klînîkî
Dabeşkirina klînîkî
Nexweşiyên Muscular
Mutasyona analîz kirin
DNM2 c.1393C>T
p.(R465W)
p.(R465W)
Mode mîras
Autosomal Recessive
Kurteya testê:
Centronuclear Myopathy (CNM) is a genetic disorder affecting Border Collies, characterized by muscle weakness and exercise intolerance. A DNA test can identify carriers and affected dogs, enabling breeders to make informed decisions to reduce the prevalence of this condition. Early detection through genetic testing can help owners manage symptoms and improve the quality of life for affected pets. Responsible breeding practices based on test results play a crucial role in preserving the health of the breed. Overall, DNA testing for CNM enhances breed welfare and promotes healthier generations of Border Collies.
Ji pakêtê peyda dibe: Basic
Ev testa DNA ji pakêta me dest pê dike tê de ye Basic - û di heman demê de beşek ji pakêtan e Basic, Standard, Advanced, Complete.
Pakêtên testa DNA-ê bibînin →Pakêta ku herî baş li gorî stratejiya weya çandinî an tenduristiya heywanên we tê hilbijêrin.
Overview of Centronuclear Myopathy (CNM) in Border Collies
Centronuclear Myopathy (CNM) is a hereditary muscle disorder found in Border Collies. Characterized by weakness and muscle atrophy, this genetic condition significantly affects the dog's motor capabilities and overall quality of life. CNM results from mutations in specific genes leading to improper muscle fiber development and function.
Nîşan û Nîşanên Klînîkî
Dogs affected by CNM typically exhibit clinical signs from a young age. Common symptoms include muscle weakness, reduced physical activity, exercise intolerance, abnormal gait, and muscle wasting. Severely affected dogs may have difficulty standing or walking, potentially impacting their ability to perform routine daily activities.
Genetic Basis of Centronuclear Myopathy
CNM in Border Collies is inherited in an autosomal recessive manner. This means a dog must inherit two copies of the mutated gene—one from each parent—to exhibit symptoms. Dogs carrying only one copy of the mutation (carriers) do not typically show signs but can pass the mutation onto offspring.
Importance of DNA Testing for CNM
DNA testing is essential for identifying the CNM mutation in Border Collies. Early identification of affected and carrier dogs helps breeders make informed decisions, preventing the spread of the condition. DNA testing enables responsible breeding practices, assisting in reducing and eventually eliminating the occurrence of this debilitating condition.
Interpretation of DNA Test Results
The DNA test clearly distinguishes three genetic statuses:
Recommendations for Breeders and Owners
Breeders are advised to conduct CNM DNA testing in breeding dogs before mating. Clear mating strategies should be selected to avoid producing affected puppies. Owners of Border Collies should consult veterinarians and genetic specialists for guidance on managing dogs diagnosed with CNM, ensuring the best possible quality of life.
Nijada ku ji bo ceribandinê tê nas kirin: Mîopatiya Navokî ya Navendî ya Li Border Collie (CNM-BC)
- Bearded Collie
- Border Collie
- Farm Collie
- Old Farm Collie
- Rough Collie
- Scottish Collie
- Scottish Rough Collie
- Scottish Smooth Collie
- Smooth Collie
🧬 Interpretation of genotypes CNM-BC
Genotype
Cî
🟡 N/N
Non-hilgir - No Risk
🟡 N/CNM-BC
Carrier - No Risk
❌ CNM-BC/CNM-BC
Bi bandor - Di rîskê de
FAQ: têgihiştina şîroveyê
Ma "Carrier" ciddî ye?
Naxêr. Ajal bi gelemperî saxlem e lê dikare mutasyonê bigihîne xwe dûndana.
Heke heywanek "Bê bandor" be?
Ew du kopiyên mutated digire. Nîşanên klînîkî li gorî têne hêvî kirin nexweşî. Divê ew neyê çandin.
Çima di navbera nêr/mê de cudahî hene?
Hin nexweşî bi zayendî ve girêdayî ne, ji ber vê yekê vegotina wan li gorî nexweşiyê diguhere zayenda heywanan.
Pêşbînî Pêşbînî
N/N (ne-hilgir)
N/CNM-BC (Barkêş)
CNM-BC/CNM-BC (Fenî)
FAQ testa DNA
Ev testa DNA-ê çi destnîşan dike?
This DNA test detects the mutation associated with Centronuclear Myopathy In Border Collie (CNM) in order to identify clear, carrier, or at-risk animals.
Çima heywanek çêdike ceribandin?
Testkirina DNA ji cotkaran re dibe alîkar ku zewacên bi ewletir plansaz bikin û xetera veguheztina mutasyonê ji nifşan re kêm bikin.
Moda mîrasê ya vê testê çi ye?
Moda mîrasê ya ku ji bo vê ceribandinê hatî ragihandin Autosomal Recessive ye.
Di vê testê de kîjan mutasyon tê analîz kirin?
This test analyses the mutation DNM2 c.1393C>T.
Ma heywanek hilgirê bi neçarî bandor dibe?
Ne hewce ye. Şîrovekirin bi şêwaza mîras û genotipa encam ve girêdayî ye.
Çavkanî
Böhm Johann, Barthélémy Inès, Landwerlin Charlène, BlanchardGutton Nicolas, Relaix Frédéric, Blot Stéphane, Laporte Jocelyn, Tiret Laurent. A dog model for centronuclear myopathy carrying the most common DNM2 mutation. Dis Model Mech. 2022 Apr 1;15(4):dmm049219. doi: 10.1242/dmm.049219. Epub 2022 Apr 14.